CN103690832A - Traditional Chinese medicinal composition for treating viral myocarditis - Google Patents
Traditional Chinese medicinal composition for treating viral myocarditis Download PDFInfo
- Publication number
- CN103690832A CN103690832A CN201310741113.2A CN201310741113A CN103690832A CN 103690832 A CN103690832 A CN 103690832A CN 201310741113 A CN201310741113 A CN 201310741113A CN 103690832 A CN103690832 A CN 103690832A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- viral myocarditis
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010047470 viral myocarditis Diseases 0.000 title claims abstract description 25
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 34
- 239000000463 material Substances 0.000 claims abstract description 28
- 239000008187 granular material Substances 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims 9
- 238000009472 formulation Methods 0.000 claims 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract description 11
- 235000004347 Perilla Nutrition 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 11
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract description 10
- 235000017491 Bambusa tulda Nutrition 0.000 abstract description 10
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract description 10
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 10
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract description 10
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract description 10
- 239000011425 bamboo Substances 0.000 abstract description 10
- 229940010454 licorice Drugs 0.000 abstract description 10
- 241000378467 Melaleuca Species 0.000 abstract description 9
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract description 9
- 235000020637 scallop Nutrition 0.000 abstract description 7
- 240000006079 Schisandra chinensis Species 0.000 abstract description 5
- 241000237503 Pectinidae Species 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000004217 heart function Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 241001521901 Tribulus lanuginosus Species 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 35
- 239000000843 powder Substances 0.000 description 19
- 239000006071 cream Substances 0.000 description 16
- 238000003756 stirring Methods 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000004375 Dextrin Substances 0.000 description 14
- 229920001353 Dextrin Polymers 0.000 description 14
- 235000019425 dextrin Nutrition 0.000 description 14
- 241001533104 Tribulus terrestris Species 0.000 description 11
- 244000303040 Glycyrrhiza glabra Species 0.000 description 10
- 241000229722 Perilla <angiosperm> Species 0.000 description 10
- 241001330002 Bambuseae Species 0.000 description 9
- 230000002107 myocardial effect Effects 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 102000011759 adducin Human genes 0.000 description 5
- 108010076723 adducin Proteins 0.000 description 5
- 238000000889 atomisation Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000007779 soft material Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000736075 Schisandra Species 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 241000237509 Patinopecten sp. Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 241000234282 Allium Species 0.000 description 2
- 241000304531 Allium macrostemon Species 0.000 description 2
- 241000037740 Coptis chinensis Species 0.000 description 2
- 244000247747 Coptis groenlandica Species 0.000 description 2
- 235000002991 Coptis groenlandica Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 241000037803 Coptis deltoidea Species 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241001657511 Lepidium apetalum Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 241000383833 Pachyphyllum Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗病毒性心肌炎的中药组合物,该药由如下重量份的中药材原料制备而成:黄连10-18份、千层塔20-30份、薤白20-30份、五味子10-18份、竹叶20-30份、苏叶10-18份、薏苡仁25-40份、蒺藜8-15份、炙甘草6-12份、葶苈子10-18份。本发明的中药组合物治疗原发性病毒性心肌炎的临床疗效显著,不仅能明显改善症状,而且能够降低AST、CK、CK-MB、LDH、a-HBDB水平,调节免疫,改善心功能。 The invention discloses a traditional Chinese medicine composition for treating viral myocarditis. The medicine is prepared from the following Chinese medicinal materials in parts by weight: 10-18 parts of Coptidis Rhizome, 20-30 parts of Melaleuca Pagoda, 20-30 parts of Scallops, and Schisandra 10-18 parts, 20-30 parts of bamboo leaves, 10-18 parts of perilla leaves, 25-40 parts of coix seed, 8-15 parts of Tribulus terrestris, 6-12 parts of roasted licorice, 10-18 parts of Tinglizi. The traditional Chinese medicine composition of the invention has remarkable clinical curative effect in treating primary viral myocarditis, not only can obviously improve symptoms, but also can reduce the levels of AST, CK, CK-MB, LDH and a-HBDB, regulate immunity and improve heart function.
Description
技术领域 technical field
本发明属于中医药技术领域,具体而言,涉及一种治疗病毒性心肌炎的中药组合物。 The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to a traditional Chinese medicine composition for treating viral myocarditis.
背景技术 Background technique
病毒性心肌炎可发生于任何年龄,以青少年多见,该病疗程长、病情易反复,治疗不及时可迁延成慢性甚至发展成心肌病,严重影响儿童健康。病毒性心肌炎早期主要表现病毒直接损害心肌,后期主要以免疫损伤为主。病毒性心肌炎的发病机制尚不完全明了,但病毒对心肌细胞的直接溶解作用和病毒诱导产生对心肌组织的自身免疫损害是病毒性心肌炎的重要发病机制。近年来,其发病率呈上升趋势,且无特效治疗方法。西药治疗主要针对原发感染和心肌炎症两方面,但现有抗病毒药物对病毒性心肌炎的疗效不能肯定。祖国医学认为,病毒性心肌炎属“心悸”、“胸痹”等证范畴。而且,中医药在此方面显示出明显优势。 Viral myocarditis can occur at any age, and it is more common in adolescents. The course of treatment is long and the condition is prone to recurrence. If the treatment is not timely, it can be chronic and even develop into cardiomyopathy, which seriously affects the health of children. In the early stage of viral myocarditis, the main manifestation is that the virus directly damages the myocardium, and in the later stage, the main manifestation is immune injury. The pathogenesis of viral myocarditis is not yet fully understood, but the direct lytic effect of the virus on myocardial cells and the autoimmune damage induced by the virus to myocardial tissue are important pathogenesis of viral myocarditis. In recent years, its incidence is on the rise, and there is no specific treatment. Western medicine treatment is mainly aimed at two aspects of primary infection and myocardial inflammation, but the curative effect of existing antiviral drugs on viral myocarditis is uncertain. Traditional Chinese medicine believes that viral myocarditis belongs to the categories of "palpitations" and "chest pain". Moreover, traditional Chinese medicine has shown obvious advantages in this respect.
发明内容 Contents of the invention
本发明的目的在于通过对传统药物药理进行研究后重新组方,提供一种疗效好、见效快、副作用小的治疗病毒性心肌炎的中药组合物。 The purpose of the present invention is to provide a traditional Chinese medicine composition for treating viral myocarditis with good curative effect, quick effect and little side effect by recombining prescriptions after studying the pharmacology of traditional medicines.
本发明的目的是这样实现的: The purpose of the present invention is achieved like this:
一种治疗病毒性心肌炎的中药组合物,由如下重量份的中药材原料制备而成:黄连10-18份、千层塔20-30份、薤白20-30份、五味子10-18份、竹叶20-30份、苏叶10-18份、薏苡仁25-40份、蒺藜8-15份、炙甘草6-12份、葶苈子10-18份。 A traditional Chinese medicine composition for treating viral myocarditis, which is prepared from the following raw materials of Chinese medicinal materials in parts by weight: 10-18 parts of Coptidis Rhizoma, 20-30 parts of Melaleuca, 20-30 parts of Scallops, 10-18 parts of Schisandra, bamboo 20-30 parts of leaves, 10-18 parts of perilla leaves, 25-40 parts of Coix seed, 8-15 parts of Tribulus terrestris, 6-12 parts of roasted licorice, 10-18 parts of Tinglizi.
优选地,如上所述治疗病毒性心肌炎的中药组合物,它由如下重量份的中药材原料制备而成:黄连13-15份、千层塔23-27份、薤白23-27份、五味子13-15份、竹叶23-27份、苏叶13-15份、薏苡仁30-35份、蒺藜10-13份、炙甘草8-10份、葶苈子13-15份。 Preferably, the traditional Chinese medicine composition for treating viral myocarditis as described above is prepared from the following Chinese medicinal materials in parts by weight: Coptidis 13-15 parts, Melaleuca 23-27 parts, Scallops 23-27 parts, Schisandra 13 parts -15 parts, 23-27 parts of bamboo leaves, 13-15 parts of perilla leaves, 30-35 parts of coix seed, 10-13 parts of Tribulus terrestris, 8-10 parts of roasted licorice, 13-15 parts of Tinglizi.
在本发明的一个最优选的实施例中,如上所述的中药组合物由如下重量份的中药材原料制备而成:黄连14份、千层塔25份、薤白25份、五味子14份、竹叶25份、苏叶14份、薏苡仁32份、蒺藜12份、炙甘草8份、葶苈子14份。 In a most preferred embodiment of the present invention, the above-mentioned traditional Chinese medicine composition is prepared from the following raw materials of Chinese medicinal materials in parts by weight: 14 parts of Coptidis Rhizome, 25 parts of Melaleuca, 25 parts of Scallop, 14 parts of Schisandra, bamboo 25 parts of leaves, 14 parts of perilla leaves, 32 parts of coix seed, 12 parts of Tribulus terrestris, 8 parts of roasted licorice, and 14 parts of Tinglizi.
优选地,上述的治疗病毒性心肌炎的中药组合物是口服制剂。 Preferably, the above-mentioned traditional Chinese medicine composition for treating viral myocarditis is an oral preparation.
再进一步优选地,上述的治疗病毒性心肌炎的中药组合物是颗粒剂。 Still further preferably, the above-mentioned traditional Chinese medicine composition for treating viral myocarditis is a granule.
本发明涉及的中药材具有如下来源:黄连选用毛茛科植物黄连Coptis chinensis Franch.三角叶黄连Coptis deltoidea C.Y.Chenget Hsiao或云连Coptis teeta Wall.的干燥根茎。千层塔选用石杉科石杉属多年生草本植物蛇足石杉的全草。薤白选用百合科植物小根蒜 Allium macrostemon Bge.的干燥鳞茎,夏、秋二季采挖,洗净,除去须根,蒸透或置沸水中烫透,晒干。竹叶选用禾本科植物淡竹的干燥叶。苏叶选用唇形科植物皱紫苏、尖紫苏等的干燥叶。薏苡仁选用禾本科植物薏苡Coix lacryma-jobi L. var. meyuan (Romen.) Stapf的种仁。蒺藜选用蒺藜科植物蒺藜Tribulus terrestris L.的干燥成熟果实。炙甘草选用为双子叶植物豆科 Leguminosae甘草 Glycyrrhiza uralensis Fisch. ,胀果甘草 G. inflata Bat., 或光果甘草 G. glabra L. 的根及根茎用蜜烘制而得。葶苈子选用独行菜(Lepidium apetalum)的成熟种子。 The Chinese medicinal materials involved in the present invention have the following sources: the rhizomes of Coptis chinensis Franch, Coptis deltoidea C.Y. Chenget Hsiao or Coptis teeta Wall. The thousand-story pagoda is made of the whole herb of the perennial herb Huperus serrata of the Huperzaceae family. The dried bulbs of Allium macrostemon Bge. are selected from Liliaceae plant Allium macrostemon Bge. They are excavated in summer and autumn, washed, removed fibrous roots, steamed or scalded in boiling water, and dried in the sun. Bamboo leaves are selected from the dry leaves of Gramineae Pachyphyllum. Perilla leaves are selected from the dry leaves of Lamiaceae plants such as wrinkled perilla and pointed perilla. Coix lacryma-jobi L. var. meyuan (Romen.) Stapf seeds are selected from the gramineous plant Coix lacryma-jobi L. var. meyuan (Romen.) Stapf. Tribulus terrestris is selected from the dried ripe fruit of Tribulus terrestris L. of Tribulus terrestris plant. Roasted licorice is obtained by roasting the root and rhizome of Glycyrrhiza uralensis Fisch., G. inflata Bat., or G. glabra L. Tinglizi is selected from the mature seeds of Lepidium apetalum.
将上述各中药材制备成本发明的复方颗粒剂的制备方法,包括如下步骤:按处方量称取清洗干净的黄连10-18份、千层塔20-30份、薤白20-30份、五味子10-18份、竹叶20-30份、苏叶10-18份、薏苡仁25-40份、蒺藜8-15份、炙甘草6-12份和葶苈子10-18份,合并,加水煎煮两次,第一次加水为药材重量的10倍量,煎煮1.5h,第二次加水为药材重量的8倍量,煎煮1.5h,合并煎液,0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏,加95%(v/v)乙醇使含醇量达75%(v/v), 搅拌,静置24小时,过滤,滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25,并回收乙醇,得浓缩液,将浓缩液喷雾干燥(条件为进风温度为100℃,出风温度为80℃,物料温度为80℃, 雾化压力为0.2兆帕,喷雾速度为5ml/s。),粉碎过80目筛,得到清膏粉;按照清膏粉:糊精1:1~3的重量比称取清膏粉、糊精,将清膏粉与糊精投入槽型混合机中,搅拌20分钟,边搅拌边缓缓加入适量乙醇溶液,至制成软材,用12目不锈钢筛制粒,65~75℃干燥2小时,取出,放凉即得所述的颗粒剂。 The preparation method of the compound granules prepared from the above-mentioned Chinese medicinal materials comprises the following steps: weighing 10-18 parts of Coptis chinensis, 20-30 parts of Melaleuca pagoda, 20-30 parts of Scallops, and 10 parts of Schisandra chinensis according to the prescription amount -18 parts, 20-30 parts of bamboo leaves, 10-18 parts of sage leaves, 25-40 parts of coix seed, 8-15 parts of Tribulus terrestris, 6-12 parts of roasted licorice and 10-18 parts of Tinglizi, combine and decoct Boil twice, add water 10 times the weight of the medicinal material for the first time, decoct for 1.5h, add water for the second time 8 times the weight of the medicinal material, decoct for 1.5h, combine the decoction, 0.07MPa, 60-70℃ Concentrate under reduced pressure to extract with a relative density of 1.15 at 65°C, add 95% (v/v) ethanol to make the alcohol content reach 75% (v/v), stir, let stand for 24 hours, filter, and the filtrate is at 0.07MPa , Concentrate under reduced pressure at 65°C to a relative density of 1.25 at 65°C, and recover ethanol to obtain a concentrated solution, which is spray-dried (conditions are that the inlet air temperature is 100°C, the outlet air temperature is 80°C, and the material temperature 80°C, atomization pressure 0.2 MPa, spray speed 5ml/s), crushed through 80-mesh sieve to obtain clear paste powder; Paste powder and dextrin, put the clear paste powder and dextrin into the tank mixer, stir for 20 minutes, slowly add an appropriate amount of ethanol solution while stirring, until the soft material is made, granulate with a 12-mesh stainless steel sieve, 65~ Dry at 75°C for 2 hours, take it out, and let it cool to obtain the granules.
本发明的中药组合物治疗原发性病毒性心肌炎的临床疗效显著,不仅能明显改善症状,而且能够降低AST、CK、CK-MB、LDH、a-HBDB水平,调节免疫,改善心功能,提示其作用可能与增加心肌供血,改善心肌代谢,营养受损心肌,改善机体免疫状态等有关。另外,本发明的药物具有医疗费用低,患者容易接受,毒副反应小的特点。 The traditional Chinese medicine composition of the present invention has remarkable clinical curative effect in treating primary viral myocarditis, not only can obviously improve symptoms, but also can reduce AST, CK, CK-MB, LDH, a-HBDB levels, regulate immunity, improve heart function, prompting Its effect may be related to increasing myocardial blood supply, improving myocardial metabolism, nourishing damaged myocardium, and improving the immune status of the body. In addition, the medicine of the present invention has the characteristics of low medical expenses, easy acceptance by patients, and little toxic and side effects.
具体实施方式 Detailed ways
以下是本发明的具体实施例,对本发明的技术方案做进一步作描述,但是本发明的保护范围并不限于这些实施例。凡是不背离本发明构思的改变或等同替代均包括在本发明的保护范围之内。 The following are specific examples of the present invention, and further describe the technical solution of the present invention, but the protection scope of the present invention is not limited to these examples. All changes or equivalent substitutions that do not depart from the concept of the present invention are included in the protection scope of the present invention.
实施例1 Example 1
生药处方:黄连14份、千层塔25份、薤白25份、五味子14份、竹叶25份、苏叶14份、薏苡仁32份、蒺藜12份、炙甘草8份、葶苈子14份。 Herbal medicine prescription: Coptidis 14 parts, Melaleuca 25 parts, Scallop 25 parts, Schisandra chinensis 14 parts, bamboo leaves 25 parts, perilla leaves 14 parts, coix seed 32 parts, tribulus terrestris 12 parts, roasted licorice 8 parts, Tinglizi 14 parts .
制备工艺:按处方量称取清洗干净的上述中药材,合并,加水煎煮两次,第一次加水为药材重量的10倍量,煎煮1.5h,第二次加水为药材重量的8倍量,煎煮1.5h,合并煎液,0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏,加95%(v/v)乙醇使含醇量达75%(v/v), 搅拌,静置24小时,过滤,滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25,并回收乙醇,得浓缩液,将浓缩液喷雾干燥(条件为进风温度为100℃,出风温度为80℃,物料温度为80℃, 雾化压力为0.2兆帕,喷雾速度为5ml/s。),粉碎过80目筛,得到清膏粉;按照清膏粉:糊精1:2.5的重量比称取清膏粉、糊精,将清膏粉与糊精投入槽型混合机中,搅拌20分钟,边搅拌边缓缓加入55%乙醇,至制成软材,用12目不锈钢筛制粒,65~75℃干燥2小时,取出,放凉即得所述的颗粒剂,按每袋15g包装。 Preparation process: Weigh the above-mentioned Chinese medicinal materials cleaned according to the prescription amount, combine them, add water to decoct twice, add water for the first time to 10 times the weight of the medicinal materials, decoct for 1.5 hours, and add water for the second time to 8 times the weight of the medicinal materials amount, decoct for 1.5h, combine the decoction, concentrate under reduced pressure at 0.07MPa, 60-70°C to an extract with a relative density of 1.15 at 65°C, add 95% (v/v) ethanol to make the alcohol content reach 75% (v/v), stir, stand still for 24 hours, filter, the filtrate is concentrated under reduced pressure at 0.07MPa and 65°C to a relative density of 1.25 at 65°C, and ethanol is recovered to obtain a concentrated solution, which is spray-dried (Conditions are that the inlet air temperature is 100°C, the outlet air temperature is 80°C, the material temperature is 80°C, the atomization pressure is 0.2 MPa, and the spray speed is 5ml/s.), crushed through a 80-mesh sieve to obtain clear cream powder ;Weigh the cream powder and dextrin according to the weight ratio of cream powder: dextrin 1:2.5, put the cream powder and dextrin into the tank mixer, stir for 20 minutes, and slowly add 55% ethanol while stirring , until soft material is made, granulate with 12 mesh stainless steel sieves, dry at 65~75°C for 2 hours, take out, let cool to get the described granules, pack in 15g per bag.
实施例2 Example 2
生药处方:黄连16份、千层塔22份、薤白26份、五味子10份、竹叶28份、苏叶15份、薏苡仁35份、蒺藜8份、炙甘草8份、葶苈子18份。 Herbal medicine prescription: Coptidis 16 parts, Melaleuca 22 parts, Allium 26 parts, Schisandra 10 parts, Bamboo leaves 28 parts, Perilla leaves 15 parts, Coix seed 35 parts, Tribulus terrestris 8 parts, Roasted licorice 8 parts, Tinglizi 18 parts .
制备工艺:按处方量称取清洗干净的上述中药材,合并,加水煎煮两次,第一次加水为药材重量的10倍量,煎煮1.5h,第二次加水为药材重量的8倍量,煎煮1.5h,合并煎液,0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏,加95%(v/v)乙醇使含醇量达75%(v/v), 搅拌,静置24小时,过滤,滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25,并回收乙醇,得浓缩液,将浓缩液喷雾干燥(条件为进风温度为100℃,出风温度为80℃,物料温度为80℃, 雾化压力为0.2兆帕,喷雾速度为5ml/s。),粉碎过80目筛,得到清膏粉;按照清膏粉:糊精1:3的重量比称取清膏粉、糊精,将清膏粉与糊精投入槽型混合机中,搅拌20分钟,边搅拌边缓缓加入55%乙醇,至制成软材,用12目不锈钢筛制粒,65~75℃干燥2小时,取出,放凉即得所述的颗粒剂,按每袋15g包装。 Preparation process: Weigh the above-mentioned Chinese medicinal materials cleaned according to the prescription amount, combine them, add water to decoct twice, add water for the first time to 10 times the weight of the medicinal materials, decoct for 1.5 hours, and add water for the second time to 8 times the weight of the medicinal materials amount, decoct for 1.5h, combine the decoction, concentrate under reduced pressure at 0.07MPa, 60-70°C to an extract with a relative density of 1.15 at 65°C, add 95% (v/v) ethanol to make the alcohol content reach 75% (v/v), stir, stand still for 24 hours, filter, the filtrate is concentrated under reduced pressure at 0.07MPa and 65°C to a relative density of 1.25 at 65°C, and ethanol is recovered to obtain a concentrated solution, which is spray-dried (Conditions are that the inlet air temperature is 100°C, the outlet air temperature is 80°C, the material temperature is 80°C, the atomization pressure is 0.2 MPa, and the spray speed is 5ml/s.), crushed through a 80-mesh sieve to obtain clear cream powder ;Weigh the clear cream powder and dextrin according to the weight ratio of clear cream powder: dextrin 1:3, put the clear cream powder and dextrin into the tank mixer, stir for 20 minutes, and slowly add 55% ethanol while stirring , until soft material is made, granulate with 12 mesh stainless steel sieves, dry at 65~75°C for 2 hours, take out, let cool to get the described granules, pack in 15g per bag.
实施例3 Example 3
生药处方:黄连10份、千层塔25份、薤白28份、五味子15份、竹叶25份、苏叶12份、薏苡仁40份、蒺藜12份、炙甘草12份、葶苈子10份。 Herbal medicine prescription: Coptis 10 parts, Melaleuca 25 parts, Allium 28 parts, Schisandra chinensis 15 parts, Bamboo leaves 25 parts, Perilla leaves 12 parts, Coix seed 40 parts, Tribulus terrestris 12 parts, Roasted licorice 12 parts, Tinglizi 10 parts .
制备工艺:按处方量称取清洗干净的上述中药材,合并,加水煎煮两次,第一次加水为药材重量的10倍量,煎煮1.5h,第二次加水为药材重量的8倍量,煎煮1.5h,合并煎液,0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏,加95%(v/v)乙醇使含醇量达75%(v/v), 搅拌,静置24小时,过滤,滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25,并回收乙醇,得浓缩液,将浓缩液喷雾干燥(条件为进风温度为100℃,出风温度为80℃,物料温度为80℃, 雾化压力为0.2兆帕,喷雾速度为5ml/s。),粉碎过80目筛,得到清膏粉;按照清膏粉:糊精1:3的重量比称取清膏粉、糊精,将清膏粉与糊精投入槽型混合机中,搅拌20分钟,边搅拌边缓缓加入55%乙醇,至制成软材,用12目不锈钢筛制粒,65~75℃干燥2小时,取出,放凉即得所述的颗粒剂,按每袋15g包装。 Preparation process: Weigh the above-mentioned Chinese medicinal materials cleaned according to the prescription amount, combine them, add water to decoct twice, add water for the first time to 10 times the weight of the medicinal materials, decoct for 1.5 hours, and add water for the second time to 8 times the weight of the medicinal materials amount, decoct for 1.5h, combine the decoction, concentrate under reduced pressure at 0.07MPa, 60-70°C to an extract with a relative density of 1.15 at 65°C, add 95% (v/v) ethanol to make the alcohol content reach 75% (v/v), stir, stand still for 24 hours, filter, the filtrate is concentrated under reduced pressure at 0.07MPa and 65°C to a relative density of 1.25 at 65°C, and ethanol is recovered to obtain a concentrated solution, which is spray-dried (Conditions are that the inlet air temperature is 100°C, the outlet air temperature is 80°C, the material temperature is 80°C, the atomization pressure is 0.2 MPa, and the spray speed is 5ml/s.), crushed through a 80-mesh sieve to obtain clear cream powder ;Weigh the clear cream powder and dextrin according to the weight ratio of clear cream powder: dextrin 1:3, put the clear cream powder and dextrin into the tank mixer, stir for 20 minutes, and slowly add 55% ethanol while stirring , until soft material is made, granulate with 12 mesh stainless steel sieves, dry at 65~75°C for 2 hours, take out, let cool to get the described granules, pack in 15g per bag. the
实施例4 Example 4
生药处方:黄连18份、千层塔20份、薤白21份、五味子18份、竹叶22份、苏叶18份、薏苡仁26份、蒺藜15份、炙甘草10份、葶苈子15份。 Herbal medicine prescription: Coptidis 18 parts, Melaleuca 20 parts, Scallop 21 parts, Schisandra chinensis 18 parts, bamboo leaves 22 parts, perilla leaves 18 parts, coix seed 26 parts, tribulus terrestris 15 parts, roasted licorice 10 parts, Tinglizi 15 parts .
制备工艺:按处方量称取清洗干净的上述中药材,合并,加水煎煮两次,第一次加水为药材重量的10倍量,煎煮1.5h,第二次加水为药材重量的8倍量,煎煮1.5h,合并煎液,0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏,加95%(v/v)乙醇使含醇量达75%(v/v), 搅拌,静置24小时,过滤,滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25,并回收乙醇,得浓缩液,将浓缩液喷雾干燥(条件为进风温度为100℃,出风温度为80℃,物料温度为80℃, 雾化压力为0.2兆帕,喷雾速度为5ml/s。),粉碎过80目筛,得到清膏粉;按照清膏粉:糊精1:3的重量比称取清膏粉、糊精,将清膏粉与糊精投入槽型混合机中,搅拌20分钟,边搅拌边缓缓加入55%乙醇,至制成软材,用12目不锈钢筛制粒,65~75℃干燥2小时,取出,放凉即得所述的颗粒剂,按每袋15g包装。 Preparation process: Weigh the above-mentioned Chinese medicinal materials cleaned according to the prescription amount, combine them, add water to decoct twice, add water for the first time to 10 times the weight of the medicinal materials, decoct for 1.5 hours, and add water for the second time to 8 times the weight of the medicinal materials amount, decoct for 1.5h, combine the decoction, concentrate under reduced pressure at 0.07MPa, 60-70°C to an extract with a relative density of 1.15 at 65°C, add 95% (v/v) ethanol to make the alcohol content reach 75% (v/v), stir, stand still for 24 hours, filter, the filtrate is concentrated under reduced pressure at 0.07MPa and 65°C to a relative density of 1.25 at 65°C, and ethanol is recovered to obtain a concentrated solution, which is spray-dried (Conditions are that the inlet air temperature is 100°C, the outlet air temperature is 80°C, the material temperature is 80°C, the atomization pressure is 0.2 MPa, and the spray speed is 5ml/s.), crushed through a 80-mesh sieve to obtain clear cream powder ;Weigh the clear cream powder and dextrin according to the weight ratio of clear cream powder: dextrin 1:3, put the clear cream powder and dextrin into the tank mixer, stir for 20 minutes, and slowly add 55% ethanol while stirring , until soft material is made, granulate with 12 mesh stainless steel sieves, dry at 65~75°C for 2 hours, take out, let cool to get the described granules, pack in 15g per bag. the
实施例5 中药颗粒剂对病毒性心肌炎患者的疗效研究 Example 5 Study on the curative effect of Chinese medicine granules on patients with viral myocarditis
符合小儿病毒性心肌炎诊断标准的病毒性心肌炎患者42例,属气阴两虚、肝郁证辨证患者,其中男22例,女20例;年龄4岁以下8例,5~1O岁23例,11~14岁11例;平均病程17.1天。所有患者冲服中药颗粒剂(按照本发明实施例1的处方和工艺制备而成)3袋/d,早中晚各一袋,连续用药3周。观察并记录用药前后的临床症状体征。治疗结束后,按如下标准统计疗效: 42 patients with viral myocarditis who met the diagnostic criteria for viral myocarditis in children were patients with Qi and Yin deficiency and syndrome differentiation of liver depression, including 22 males and 20 females; 8 cases were under 4 years old, and 23 cases were 5-10 years old. 11 cases aged 11 to 14; the average course of disease was 17.1 days. All patients took 3 bags of traditional Chinese medicine granules (prepared according to the prescription and process of Example 1 of the present invention) every day, one bag each in the morning, noon and evening, for 3 consecutive weeks. Observe and record the clinical symptoms and signs before and after medication. After the treatment, the curative effect was counted according to the following standards:
显效:用药7~21天后主要症状消失或大部分消失,体征、心电图及心肌酶谱正常或接近正常; Significantly effective: after 7-21 days of medication, the main symptoms disappear or most of them disappear, and the signs, electrocardiogram and myocardial enzyme spectrum are normal or close to normal;
有效:用药7~21天后主要症状部分消失,体征、心电图及心肌酶谱有明显改善; Effective: after 7 to 21 days of medication, the main symptoms partially disappeared, and the signs, electrocardiogram and myocardial enzyme spectrum were significantly improved;
无效:用药7~21天后未达到疗效标准或出现严重心律失常或心源性休克。 Ineffective: After 7-21 days of medication, the curative effect standard is not reached or severe arrhythmia or cardiogenic shock occurs.
采用本发明的中药颗粒剂对42例病毒性心肌炎患者的治疗结果是:显效25例,有效14例,无效3例,总有效率92.86%。 The treatment results of 42 patients with viral myocarditis by adopting the traditional Chinese medicine granules of the present invention are: 25 cases are markedly effective, 14 cases are effective, 3 cases are ineffective, and the total effective rate is 92.86%.
患者治疗前后心肌酶谱改善情况比较见表l。 The improvement of myocardial enzyme spectrum before and after treatment is compared in Table 1.
表1 患者治疗前后心肌酶谱改善情况比较 Table 1 Comparison of improvement of myocardial enzyme spectrum in patients before and after treatment
与治疗前相比,* P<0.05。 * P <0.05 compared with before treatment.
另外,治疗结束后未发现患者对药物有过敏反应及不耐受现象,血、尿、便常规,心电图,肝肾功能未见异常。 In addition, after the treatment, no allergic reaction or intolerance to the drug was found in the patient, and no abnormalities were found in blood, urine, stool routine, electrocardiogram, liver and kidney function.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310741113.2A CN103690832B (en) | 2013-12-30 | 2013-12-30 | A kind of traditional Chinese medicine composition for treating viral myocarditis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310741113.2A CN103690832B (en) | 2013-12-30 | 2013-12-30 | A kind of traditional Chinese medicine composition for treating viral myocarditis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103690832A true CN103690832A (en) | 2014-04-02 |
| CN103690832B CN103690832B (en) | 2015-09-09 |
Family
ID=50352602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310741113.2A Expired - Fee Related CN103690832B (en) | 2013-12-30 | 2013-12-30 | A kind of traditional Chinese medicine composition for treating viral myocarditis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103690832B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189598A (en) * | 2014-09-18 | 2014-12-10 | 邓新连 | Traditional Chinese medicine for treating qi stagnation and blood stasis type viral myocarditis |
| CN104474225A (en) * | 2014-12-29 | 2015-04-01 | 牟利江 | Medicine for treating viral myocarditis and preparation method |
| CN104906438A (en) * | 2015-07-03 | 2015-09-16 | 车莉 | Medicine for treating acute myocarditis |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1785357A (en) * | 2005-11-14 | 2006-06-14 | 咸阳步长医药科技发展有限公司 | Chinese medicinal preparation for treating virus myocaraitis, its preparation method and quality control method |
| CN101757423A (en) * | 2008-10-24 | 2010-06-30 | 常州善美药物研究开发中心有限公司 | Traditional Chinese medicine composition for treating myocarditis and preparation method thereof |
| CN103520630A (en) * | 2013-10-23 | 2014-01-22 | 孙丽 | Traditional Chinese medicine for treating heart-qi deficiency syndrome type angina pectoris |
| CN103721030A (en) * | 2012-10-15 | 2014-04-16 | 青岛信立德中药技术研究开发有限公司 | Traditional Chinese medicine composition used for treating viral myocarditis |
-
2013
- 2013-12-30 CN CN201310741113.2A patent/CN103690832B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1785357A (en) * | 2005-11-14 | 2006-06-14 | 咸阳步长医药科技发展有限公司 | Chinese medicinal preparation for treating virus myocaraitis, its preparation method and quality control method |
| CN101757423A (en) * | 2008-10-24 | 2010-06-30 | 常州善美药物研究开发中心有限公司 | Traditional Chinese medicine composition for treating myocarditis and preparation method thereof |
| CN103721030A (en) * | 2012-10-15 | 2014-04-16 | 青岛信立德中药技术研究开发有限公司 | Traditional Chinese medicine composition used for treating viral myocarditis |
| CN103520630A (en) * | 2013-10-23 | 2014-01-22 | 孙丽 | Traditional Chinese medicine for treating heart-qi deficiency syndrome type angina pectoris |
Non-Patent Citations (1)
| Title |
|---|
| 无: ""中药治疗病毒性心肌炎"", 《首都医药》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189598A (en) * | 2014-09-18 | 2014-12-10 | 邓新连 | Traditional Chinese medicine for treating qi stagnation and blood stasis type viral myocarditis |
| CN104474225A (en) * | 2014-12-29 | 2015-04-01 | 牟利江 | Medicine for treating viral myocarditis and preparation method |
| CN104474225B (en) * | 2014-12-29 | 2015-07-08 | 牟利江 | Medicine for treating viral myocarditis and preparation method |
| CN104906438A (en) * | 2015-07-03 | 2015-09-16 | 车莉 | Medicine for treating acute myocarditis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103690832B (en) | 2015-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102813904B (en) | Compound medicine for treating anaphylactic rhinitis-asthma syndrome and preparation method and application thereof | |
| CN1471953A (en) | A kind of medicinal plant composition for treating AIDS patients | |
| CN103690832B (en) | A kind of traditional Chinese medicine composition for treating viral myocarditis | |
| CN101940621B (en) | Chinese medicinal composition and preparation for relaxing bowel and preparation method thereof | |
| CN103463425B (en) | A traditional Chinese medicine extract for treating blood stasis and internal resistance, its preparation and preparation method | |
| CN111973651A (en) | Use of licorice root for treating diseases related to intestinal flora disturbance | |
| CN105582124B (en) | A kind of traditional Chinese medicine for treating constipation and preparation method thereof | |
| CN105267559B (en) | A kind of drug and preparation method thereof for treating diabete peripheral herve pathology | |
| CN100569263C (en) | A kind of pharmaceutical composition for treating stomachache and preparation method thereof | |
| CN101167904B (en) | A kind of pharmaceutical composition for treating hyperlipidemia and preparation method thereof | |
| CN104524308A (en) | Chinese herb decoction for treating sicca syndrome and making method thereof | |
| CN103386113A (en) | Traditional Chinese medicine composition, extractive and preparation for treating swine transmissible gastroenteritis and applications of Chinese medicine composition, extractive and preparation | |
| CN103690825A (en) | Weight reduction health care traditional Chinese medicine capsules | |
| CN106110132A (en) | A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof | |
| CN107952036B (en) | Traditional Chinese medicine preparation for reducing blood sugar and preparation method thereof | |
| CN105031339A (en) | Traditional Chinese medicine composition for treating stomatitis | |
| CN104758676A (en) | Medicine for treating damp-heat in resistance-type epigastric pain | |
| CN105797092B (en) | Yiyuan anti-cold mixture | |
| CN104667020B (en) | A kind of pharmaceutical composition for treating anaphylactoid purpura and preparation method thereof | |
| CN109125576A (en) | A kind of traditional Chinese medicine preparation for adjuvant treatment of gastritis and production method | |
| CN111743952A (en) | The use of habitat in regulating gut microbes | |
| CN108186909A (en) | The Chinese medicine composition and its compound preparation of improvement insulin resistance syndrome and application | |
| CN101879302A (en) | A compound traditional Chinese medicine for treating chronic arrhythmia and its preparation method | |
| CN118831142A (en) | Traditional Chinese medicine composition for improving antibody titer of novel coronavirus vaccine | |
| CN121466259A (en) | Eighteen-ingredient turbidity-eliminating composition and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170503 Address after: 226200 Hopewell Town, Qidong, Jiangsu, Nantong Patentee after: QIDONG JIULONG SHUNZHOU TOY FACTORY Address before: 266200 Jimo, Qingdao, the Yellow River, No. two, No. Road, building 25, building 182 Patentee before: Wang Xueyan |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150909 |
